While MPNST remains a challenging malignancy, several promising advances are underway: MEK Inhibitors in NF1-Associated MPNST Given the dysregulation of the RAS/RAF/MEK pathway in NF1-related tumors, MEK inhibitors like selumetinib have shown efficacy in benign plexiform neurofibromas
Fine lines, wrinkles, and volume loss become more noticeable
If reconstituted: refrigerate (~28C)
Evidence and Clinical Research Evidence-Level Definitions: Established clinical evidence: Supported by multiple peer-reviewed human studies
A total of 1 g of RNA was then reverse-transcribed into complementary DNA (cDNA) using the HiScript III All-in-one RT SuperMix (Vazyme, China)
Clinical evidence suggests weight regain may potentially occur if the medication is stopped, reinforcing the need to adhere to long-term lifestyle changes directed by your doctor